All companies
Visit website
MORARI, INC.
OperatingMorari, Inc.
Healthcare · Fitness · Founded 2020
Climax delay patch for MOR intimate experience
Post-money valuation ⓘ
$8.7M
As of Apr 2025 · from MORARI, INC. Preferred Stock 2 · pre-money + amount raised, not a traded price
Total raised
$652,512
Across 2 rounds since 2022
Latest share price
$1.10
MORARI, INC. Preferred Stock 2 offering price
Financials
FY2020–FY2025 · from SEC filings · hover any figure for its source$0
−$337K
2020
$0
−$445K
2021
$0
−$1.2M
2022
$0
−$646K
2023
$0
−$623K
2024
$61K
−$251K
2025
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Income statement
Revenue
$0
$0
$0
$0
$0
$60,835
Cost of goods sold
$0
$0
$0
$0
$0
$66,556
Gross margin
—
—
—
—
—
-9%
Net income
-$337,020
-$445,461
-$1,164,386
-$646,440
-$623,360
-$251,048
Taxes paid
$0
$0
$0
$0
$10,814
$18,065
Balance sheet
Cash
$298,573
$742,398
$350,630
$653,265
$151,935
$10,381
Accounts receivable
$0
$0
$0
$0
$0
$0
Total assets
$315,341
$792,254
$409,690
$724,213
$222,884
$144,340
Short-term debt
$15,490
$364
$0
$0
$222,504
$300,303
Long-term debt
$0
$0
$0
$100,000
$141,600
$141,600
Total liabilities
$15,490
$364
$0
$100,000
$364,104
$441,903
Other
Headcount
—
1
—
1
—
1
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$8.6M
post-money
$8.7M
post-money
MORARI, INC. Preferred Stock 1
MORARI, INC. Preferred Stock 2
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised — / $294KPost-money $8.7M
Raised $652.5K / $1.1MInvestors 285Post-money $8.6M
Reg CF annual-report compliance
Not requiredFewer than 300 holders of record
Filed 2 of 4 annual reports (FY2022–FY2025)
285 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
Source: ManualCIK 0001943904Share price $1.10
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.